| Assay Method Information | |
| | In Vitro Evaluation of EPAC1 Inhibition |
| Description: | To explore the SARs and examine how the modifications on the isoxazole ring affect biological activities of newly synthesized analogues, we first evaluated their ability to inhibit EPAC1-mediated Rap1b-bGDP exchange activity using purified recombinant full-length EPAC1 proteins. Previous hit 1 was used as the reference compound, with an IC50 value of 10.8 μM in inhibiting EPAC1 (Zhu et al., Sci. Rep. (2015) 5:9344). |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |